Home › Funds › Vivo Capital, LLC › MSLE

Vivo Capital, LLC position in MSLE

Satellos Bioscience Inc · Health Care

Vivo Capital, LLC reported holding 813,666 shares of MSLE (Satellos Bioscience Inc) in its Q3 2026 13F filing — a position valued at US$6.9M, representing 0.79% of its reported portfolio and ranking #33 among its reported holdings. Vivo Capital, LLC has disclosed MSLE holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)813.67K sh
Reported value held$6.92M
Portfolio Weight0.79%
First reportedQ1 2026
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Vivo Capital, LLC's MSLE position evolved

Vivo Capital, LLC first disclosed a stake in MSLE in Q1 2026 at 813,666 shares (US$4.6M). The position peaked in Q3 2026 at 813,666 shares, worth US$6.9M. Across 3 filings, Vivo Capital, LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 813,666 shares valued at US$6.9M.

Quarter by quarter

QuarterSharesValueChange
Q1 2026 813.67K $4.58M New
Q2 2026 813.67K $6.33M Hold
Q3 2026 813.67K $6.92M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MSLE and 13F data

MSLE (Satellos Bioscience Inc) is a Health Care company. 30 other funds we track also report a position in MSLE — the largest reported positions include SPHERA FUNDS MANAGEMENT LTD. (US$5.1M), Stonepine Capital Management, LLC (US$3.7M), Avidity Partners Management LP (US$3.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MSLE

All MSLE fund holders →

FAQ

How long has Vivo Capital, LLC held MSLE?

Vivo Capital, LLC has disclosed MSLE holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Vivo Capital, LLC's current position in MSLE?

As of Q3 2026, Vivo Capital, LLC holds 813.67K shares of MSLE (Satellos Bioscience Inc), valued at $6.92M, representing 0.79% of its reported portfolio and ranking #33.

Has Vivo Capital, LLC been buying or selling MSLE?

In the latest 13F filing (Q3 2026), Vivo Capital, LLC held unchanged its position in MSLE. The position peaked in Q3 2026 at 813.67K shares.

Which other funds hold MSLE?

Other major institutional holders of MSLE include SPHERA FUNDS MANAGEMENT LTD., Stonepine Capital Management, LLC, Avidity Partners Management LP, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.